Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 9, 1997, Pages 895-900

  Mastalerz, L ^a   Milewski, M ^a   Duplaga, M ^a   Nizankowska, E ^a   Szczeklik, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aspirin induced asthma; Eosinephil; Nasal provocation; Rhinitis

Indexed keywords

ACETYLSALICYLIC ACID; FLUTICASONE PROPIONATE; PLACEBO;

ADULT; ALLERGIC RHINITIS; ANALGESIA; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOLOGY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RHINOMANOMETRY; SCORING SYSTEM; SCREENING;

EID: 0030773311     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb01248.x     Document Type: Article

References (38)

1. Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, editors. Allergy: principles and practice. St Louis, MO: Mosby Year-Book, 1993:1747-65.
2. Kowalski ML, Sliwiriska-Kowalska M, Igarashi Y, et al. Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol 1993;91:580-98.
3. Szczeklik A. Aspirin-induced asthma. In: Vane JR, Bolting RM, editors. Aspirin and other salicylates. London: Chapman and Hall, 1992:548-75.
4. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ 1975;l:67-9.
5. Ortolani C, Mirone C, Fontana A, et al. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann Allergy 1987;59:106-12.
6. Christie PE, Tagari P, Ford-Hutchinson AW, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.
7. Ferreri NR, Rowland WC, Stevenson DD, Spilberg HL. Release of leukotrienes, prostaglandins and histamine into nasal secretion of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988;137:847-54.
8. Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy 1996;26:807-14.
9. Sladek K, Szczeklik A. Cysteinyl leukotriene overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 1993;6:391-9.
10. Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994;49:940-6.
11. Szczeklik A, Sladek K, Dworski R, et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin sensitive asthmatics. Am J Respir Crit Care Med 1996; 154:1608-14.
12. Picado C, Ramis I, Rosellô J, et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992;145:65-9.
13. Dolovich J, Ohtoshi T, Jordana M, Gauldie J, Denburg J. Nasal polyps: local inductive microenvironment in the pathogenesis of the inflammation. In: Mygind N, Pipkorn U, Ridah L, editors. Rhinitis and asthma. Copenhagen: Munksgaard, 1990:233-41.
14. Hamilos DL, Leung DYM, Wood R, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyps (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-cc. Am J Respir Cell Mol Biol 1996;15:443-5.
15. Nizankowska E, Szczeklik A. Glucocorticoids attenuate aspirin precipitated adverse reactions in aspirin-intolerant patients with asthma. Ann Allergy 1989;63:157-62.
16. Banov CH, Blumenthal M, Frazer H, et al. Once daily intranasal fluticasone propionate is effective for perennial allergie rhinitis. Ann Allergy 1994;73:240-6.
17. Richards DH, Milton CM. Fluticasone propionate aqueous nasal spray: a well-tolerated and effective treatment for children with perennial rhinitis. Pediatr Allergy Immunol 1996;7:35-43.
18. Watson WTA, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91:97-101.
19. Mygind N, Dahl R. The rationale for use of topical corticosteroids in allergic rhinitis. Clin Exp Allergy 1996;26 Suppl 3:2-10.
20. Huizing EH. The cellular and clinical aspects of treating rhinitis with fluticasone propionate. Eur Respir Rev 1994; 4:244-75.
21. Szczeklik A, Nizankowska E. Pharmacological agents in bronchial provocation tests. In: Braga PC, Dal Negro R, editors. Methods in asthmology. Berlin: Springer-Verlag, 1993:253-64.
22. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Standardization of nasal provocation test with lysineaspirin for diagnosis of aspirin intolerance in asthma. Allergy Clin Immunol News 1994; Suppl 2:156.
23. Milewski M. Nasal challenge test with lysine-aspirin in diagnosis of aspirin-induced asthma. Thesis. Cracow: Jagiellonian University School of Medicine, 1996.
24. Mygind N, Dahl R. Challenge tests in nose and bronchi: pharmacological modulation of rhinitis and asthma. Clin Exp Allergy 1996;26 Suppl 3:39-43.
25. Lozewicz S, Wang J, Duddle J, et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992;89:951-7.
26. Juliusson S, Holmberg K, Karlsson G, Enerbuck L, Pipkorn U. Mast cells and mediators in the nasal mucosa after allergen challenge. Effect of four weeks treatment with topical glucocorticoid. Clin Exp Allergy 1993;23:591-9.
27. Rak S, Jacobson MR, Sudderick RM. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24:930-9.
28. Braat J, Ainge G, Rijntjes E. Lack of effect of benzalkonium chloride (BCK) on the cilia of the nasal mucosa in patients with perennial allergic rhinitis: a combined functional, light- and electron microscopy (SEM and TEM) study. Clin Exp Allergy 1995;25:957-65.
29. Karlsson G, Juliusson S, Balder B, Smith DL, Holmberg K. Treatment of nasal polyps with fluticasone propionate aqueous nasal spray [Abstract]. Allergy 1995;50 Suppl 26:191.
30. Fischer AR, Rosenberg MA, Lilly CM, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994;94:1046-56.
31. Dahlen S-E, Nizankowska E, Dahlen B, et al. The Swedish-Polish treatment study with the 5-lipoxygenase inhibitor Zileuton in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1995;151:A376.
32. Gryglewski RJ, Panczenko B, Korbut R, Grodziriska L, Ocetkiewicz A. Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pigs. Prostaglandins 1975;10:343-55.
33. Nakanano T, Ohara O, Teraoka H, Arita H. Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 1990;265:12745-8.
34. Sebald RJ, Sheller JR, Gates JA, Roberts LJ II, FitzGerald GA. Inhibition of eicosanoid biosynthesis by glucocorticosteroids in humans. Proc Natl Acad Sei U S A 1990;87:6974-8.
35. Manso G, Baker AJ, Taylor IK, Fuller R\V. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans. Eur Respir J 1992;5:712-16.
36. Dworski R. Eicosanoid regulation by glucocorticosteroids in asthma. In: Szczeklik A, Gryglewski RJ, Vane J, editors. Eicosanoids, aspirin and asthma. New York: Marcel Dekker (in press).
37. Szczeklik A. Mechanism of aspirin-induced asthma. Allergy 1997;52:613-19.
38. Newton R, Kuitert LM, Slater DM, Adcock SM, Barnes PJ. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sei 1997;60:67-78.